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Clusterin is up-regulated in glomerular mesangial cells in com- factors and activation of the glomerular cells following
plement-mediated injury. C5b-9 insertion [4, 5]. To protect themselves from inap-
Background. Clusterin is a soluble complement regulatory propriate complement activation, glomerular cells areprotein that binds to C5b-7 and inhibits generation of mem-
endowed with membrane-bound complement regulatorybrane attack complex, C5b-9. Glomerular deposition of clus-
proteins, which have been the focus of nephrology stud-terin has been observed in human and experimental membra-
nous nephropathy in association with C5b-9 and immune ies [4, 6, 7]. However, relatively little is known about
deposits. However, it is controversial as to whether clusterin the roles of soluble complement regulatory proteins in
observed in glomeruli is synthesized by the resident glomerular
glomerulonephritis.cells or is derived from the circulation. We examined whether
Among the various soluble complement regulatoryclusterin is expressed by resident glomerular cells exposed to
complement-mediated injury. proteins, factor H was shown to participate in the patho-
Methods. In vitro, cultured mesangial cells were exposed to genesis of glomerular diseases. Recent studies by Jansen
antithymocyte serum immunoglobulin G and 5% normal rat et al and Hogasen et al showed that factor H deficiencyserum as a complement source. In vivo, we induced anti-Thy1
causes membranoproliferative glomerulonephritis in pigsnephritis in rats and examined the kidneys on days 8 and 29.
[8, 9]. Clusterin, another soluble complement-regulatoryResults. We observed increased expression of clusterin in
cultured rat glomerular mesangial cells stimulated by sublytic protein, may also play an important role in immune-
complement attack. We also demonstrated that in comparison mediated glomerular injury, as perfusion of isolated kid-
with control rats, both a marked increase in clusterin mRNA
neys with anti-Fx1A antibody resulted in enhanced glo-in the glomeruli and marked deposition of clusterin protein in
merular C5b-9 formation and increased proteinuriathe mesangial area occurred in the OX-7–treated rats on day
8 in association with C5b-9 deposition and on day 29. when clusterin-depleted serum was utilized [10].
Conclusion. Clusterin was induced in glomerular mesangial Clusterin is an 80 kD heterodimeric glycoprotein first
cells during the course of immune-mediated injuries. This up- isolated from ram rete testis fluid [11–13]. This proteinregulation of clusterin may play a critical role in protecting
has been identified independently by some other groupsmesangial cells from complement attack.
and has various names: sulfated glycoprotein 2 (SGP-2)
[14], glycoprotein III (GP-III) [15, 16], testosterone-
repressed prostrate message (TRPM-2) [17, 18], glyco-Complement activation plays a critical role in the
protein 80 kD (Gp80) [19], serum protein having twopathogenesis of many forms of glomerulonephritis [1–3].
40 kD subunits (SP-40,40) [20], cytolysis inhibitor (CLI)The mechanisms through which complement activation
[21], message induced by v-src oncogene (T64) [22], apo-leads to tissue injury include generation of chemotactic
lipoprotein J (Apo J) [23, 24], pADHC-9, pTB-16, K-661
(gene clones) [25–28], and others. Clusterin is detected in
Key words: apoptosis, OX-7, C5b-9, anti-Thy1 nephritis, membranous
most tissues and enhanced or induced at times of tissuenephropathy, tissue injury, serum protein 40,40, membrane attack com-
plex. injury or remodeling [29]. Various physiological func-
tions have been tentatively attributed to clusterin, includ-Received for publication June 7, 1999
ing the role of a circulating regulator of C5b-9 formationand in revised form July 6, 2000
Accepted for publication July 17, 2000 that binds to C5b-7 and inhibits the generation of mem-
brane attack complex [10, 21, 30, 31].Ó 2001 by the International Society of Nephrology
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The present study investigates the role of a soluble normal rat serum after ATS sensitization, in DMEM
alone after ATS sensitization, in 5% normal rat serumcomplement regulatory protein, clusterin, in immune-
mediated mesangial injury. without ATS sensitization, or in 5% C6-deficient PVG
rat serum (Bantin and Kingman Universal, Edmonds,
WA, USA) after ATS sensitization and 5% C6-sufficient
METHODS
PVG rat serum after ATS sensitization. The complement
Mesangial cell culture status of PVG rats has been described elsewhere [35].
The supernatants were removed and concentrated byMesangial cells were obtained by culturing glomeruli
isolated from the kidneys of 200 to 250 g male Wistar Ultrafree-MC Centrifugal Filter Units (10,000 NMWL;
Millipore, Bedford, MA, USA).rats by a conventional sieving method [32]. The cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM) The protein concentrations of the concentrated reten-
tate were measured by DC protein assay (Bio-Rad, Her-supplemented with 20% fetal calf serum (FCS; JRH Bio-
sciences, Lenexa, KS, USA), 2 mmol/L l-glutamine, 100 cules, CA, USA). One hundred micrograms of protein
were loaded in each lane, and the sodium dodecyl sulfate-U/mL penicillin, and 100 mg/mL streptomycin (Wako
Pure Chemical Industries, Osaka, Japan). polyacrylamide gel electrophoresis (SDS-PAGE) was
performed under reducing conditions. To detect clus-
Complement-mediated cell lysis assay terin protein, 5 mg/mL of rabbit anti-rat clusterin anti-
body (Upstate, Lake Placid, NY, USA) [36] was used.The almost confluent mesangial cells in 12-well plates
were sensitized with 300 mL of antithymocyte serum The bound antibody was detected with 1 mg/mL of alka-
line phosphatase-conjugated anti-rabbit IgG (Promega,(ATS) antibody (3.5 mg/mL) for 30 minutes at room
temperature. After the cells were washed once with Madison, WI, USA). BCIP/NBT tablets (Sigma Fast;
Sigma Chemical) were used as a substrate. The gel wasphosphate-buffered saline (PBS), they were incubated
with 5% normal rat serum as a complement source for stained with Commassie brilliant blue, and all the lanes
of the stained gel were confirmed to be equivalent by1.5 hours at 378C together with DMEM. Cell lysis was
quantitated using a lactate dehydrogenase (LDH) assay visual inspection. To quantitate the clusterin signals, den-
sitometry was performed using Macintosh-based NIHkit (Wako Diagnostics) as follows: Kinetic determination
of LDH was based on the spectrophotometric method image software (version 1.61, written by W. Rasband,
National Institutes of Health, Bethesda, MD, USA).of Wroblewski and LaDue [33]. The activity of LDH was
determined from the reductive ability of nicotinamide
Preparation of a monoclonal anti-rat Thy1 antibodyadenine dinucleotide, which was produced as lactate was
oxidized to pyruvate. A hybridoma cell line producing a monoclonal anti-
body against rat Thy-1.1 (OX-7, IgG1) was purchasedThe background value was estimated utilizing cells
incubated with serum without sensitization. After the from the European Collection of Animal Cell Cultures
(Porton Down, Salisbury, UK). The hybridoma was cul-assays, all cells were lyzed with 2% Triton X-100 (Sigma
Chemical Co., St. Louis, MO, USA), and the percentage tured in RPMI-1640 medium (Nissui Seiyaku Co., Tokyo,
Japan) containing 10% fetal bovine serum (Cell Cultureof complement-mediated cell lysis was calculated.
Laboratories, Cleveland, OH, USA). Cells (1 3 106)
Western blotting analysis suspended in 0.5 mL of RPMI-1640 were inoculated into
the peritoneal cavities of 8- to 10-week-old male BALB/cMesangial cells (,106/cm2) were passaged into 12-well
plates and grown until almost confluent. Goat ATS im- mice (Shizuoka Laboratory of Animals, Shizuoka, Ja-
pan), which had been injected intraperitoneally with in-munoglobulin (Ig) G was purified using a caprylic acid
precipitation method [34]. The cells were sensitized with complete Freund’s adjuvant seven days earlier. Ascitic
fluid was obtained from the mice two weeks after the300 mL of ATS antibody (3.5 mg/mL) for 30 minutes at
room temperature. After the cells were washed once hybridoma injection, and the supernatants of the ascitic
fluid after centrifugation were pooled. The Ig fractionwith PBS, they were incubated for 1.5 hours at 378C with
5% normal rat serum as a complement source together was precipitated with 50% saturated ammonium sulfate
and dialyzed against PBS. The crude antibodies werewith DMEM. After being washed further, they were
incubated with 0.5% FCS for 0, 12, 24, 48, and 72 hours applied to a Protein A column (BioRad Laboratories)
to purify the IgG. The purified antibody was finally dis-at 378C to determine the time course for changes in
clusterin expression levels. As a time control, DMEM solved in PBS, pooled, and stocked at 2808C.
alone was used instead of ATS and 5% normal rat serum.
Anti-Thy1 nephritisTo confirm the effect of the assembly of the C5b-9 on
clusterin expression, mesangial cells were incubated with All animal experimentation was conducted in accord
with the Guide for Animal Experimentation (Faculty of0.5% FCS for 24 hours after intensive washing with PBS,
after incubation under the following conditions: in 5% Medicine, University of Tokyo, Tokyo, Japan). Male
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Wistar-Kyoto (WKY) rats (6 weeks old) were purchased In situ hybridization
from Charles River Japan (Yokohama, Japan), and after In situ hybridization was performed according to the
preliminary breeding for 1 week, they received a 1.2 protocol developed by Miyazaki et al [39]. Briefly, frozen
mg/kg body weight intravenous injection of IgG1 (OX-7) sections (4 mm thick) were fixed in 4% paraformalde-
mouse monoclonal anti-Thy1.1 antibodies (N 5 12) or hyde in PBS, and then they were deproteinized by HCl
vehicle (control, N 5 12). The kidneys were harvested and digested with proteinase K (Sigma Chemical Co.).
8 days or 29 days after treatment. One kidney was disag- The specimens were prehybridized in a prehybridization
gregated by sieving to separate out the glomeruli [32]. buffer, drained, and hybridized overnight with digoxi-
The other kidney was embedded in 22-oxacalcitriol (Lab- genin (DIG)-labeled oligonucleotide probe in the prehy-
Tek Products; Miles Laboratories, Naperville, IL, USA) bridization buffer. After hybridization, the DIG-labeled
probe was visualized by immunohistochemical stainingand snap frozen in acetone in liquid nitrogen for frozen
using a mouse monoclonal anti-DIG antibody (1333062;sections.
Boehringer, Mannheim, Germany), horseradish peroxi-
RNA extraction and Northern blot analysis dase (HRP)-conjugated rabbit anti-mouse antibody (Dako
P260), and HRP-conjugated swine anti-rabbit antibodyTotal RNA was extracted from isolated glomeruli and
(Dako P399). Color was developed with diaminobenzi-cultured mesangial cells, which were incubated with
dine tetrahydrochloride in 0.05 mol/L Tris-HCl, pH 7.6,0.5% FCS for 24 hours after the incubation in 5% normal
and 0.03% H2O2. Sections were briefly counterstainedrat serum with ATS sensitization or with DMEM alone
with Methyl Green (Vector Laboratories, Burlingame,by the acid guanidinium isothiocyanate phenol chloro-
CA, USA).form method [37]. The total RNA (10 mg per each lane)
To evaluate the specificity of the technique, three typeswas separated by formaldehyde/1.0% agarose gel elec-
of control experiments were carried out as follows: First,trophoresis and transferred onto a nylon membrane (Hy-
pretreatment with RNase (Boehringer Mannheim Bio-bond N; Amersham, Buckinghamshire, UK). To prepare
chemica 109169) was performed after proteinase K di-cDNA probe for clusterin, total RNA was extracted from
gestion, and thereafter, sections were prehybridized andcultured rat mesangial cells as described previously in
hybridized. Second, a sense probe complementary to thethis article and was reverse-transcribed using SuperScript
antisense probe was reacted with the section in place ofII reverse transcriptase (Life Technologies, Grand Is-
the antisense probe. Finally, a competitive study wasland, NY, USA) in a 20 mL reaction volume. One microli-
performed by adding a 100-fold excess amount of homol-ter of the reaction was then polymerase chain reaction
ogous or unrelated, unlabeled oligonucleotides to the(PCR) amplified using the sense primer 59-ATGAAGA
hybridization buffer together with the antisense probe.
TTCTCCTGCTGTGTGTGGCAC-39 and the antisense
primer 59-CTGTCTCATTCCATGCGGCTTTTCC-39. Probes and labeling
These oligonucleotide sequences were derived from the We selected a 50 base sequence complementary to
published rat clusterin sequence [38]. The 1349 bp PCR the sequences from number 601 to number 650 of rat
fragment amplified from the RNA of rat mesangial cells clusterin cDNA [38]. The sequence used in the present
was cloned into the plasmid vector pCR2.1 (Invitrogen study showed no significant similarity with any other
Corp, Carlsbad, CA, USA) and confirmed to represent known sequences in the gene data bank.
the rat clusterin by sequencing analysis. Three hundred Fifty picomoles of the oligonucleotide probe were la-
forty bp Pst I fragments of rat clusterin from the plasmid beled using a DIG oligonucleotide tailing kit according
clones were prepared for a probe and labeled with [a-32P] to the standard protocol (Boehringer 1417-231). Free
dCTP (Amersham) by a random primer method. The DIG was removed by ethanol precipitation and dissolved
specific activity of the probe was 5 to 9 3 108 cpm/mg in diethylpyrocarbonate-treated water.
cDNA. Hybridization was performed at 428C in 0.87
Renal histology and immunohistochemistrymol/L NaCl, 50% formamide, 0.5% SDS, and 120 mg/mL
salmon sperm DNA. The membrane was washed in 0.1 3 For the detection of clusterin, anticlusterin Ig purified
standard saline citrate (SSC) and 0.1% SDS at 508C and from anticlusterin rabbit serum [40] by Protein A Sepha-
autoradiographed. The radioactivity of the correspond- rose CL-4B (Pharmacia) was used at a dilution of 1:100.
ing bands was measured quantitatively by Fuji BAS 2000 Frozen sections (4 mm thick) were methanol/acetone
Bio-Image Analyzer (Fuji Film, Tokyo, Japan). After fixed at 2208C for 10 minutes and stained using the
the radioactive probes were stripped off the membranes, diaminobenzidine detection system (HistoFine SAB-PO
they were rehybridized with 32P-labeled cDNA probes of Kit; Nichirei, Tokyo, Japan). Briefly, after one hour of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) incubation at room temperature with the primary anti-
body, the sections were incubated with a biotinylatedand used as an internal control.
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goat anti-rabbit IgG antibody for 30 minutes, followed RESULTS
by a 30-minute incubation with a HRP avidin D (Vector Expression of clusterin was up-regulated by
Laboratories). Color was developed by incubation with complement-mediated injury in rat mesangial cells
diaminobenzidine and hydrogen peroxide, and the sec- To determine whether clusterin was up-regulated by
tions were counterstained with methyl green. For clus- C5b-9 formation, we exposed cultured mesangial cells to
terin, negative controls consisted of sections in which sublytic complement attack. When sensitized mesangial
cells were incubated with 5% normal rat serum as anormal rabbit IgG was substituted for primary antibody.
complement source, no more than 2.5% complement-
mediated cell lysis was observed (1.34 6 1.09%; fourSemiquantitation of immunohistochemical staining
separate experiments were performed in triplicate).Semiquantitation of immunohistochemical staining
The effects of complement attack on the expression
was performed in a blinded fashion on the frozen sections of clusterin protein in rat mesangial cells were examined
[41]. Twenty glomeruli were randomly selected in each by Western blotting analysis. The temporal profile of
rat and staining was scored as follows: 0 5 very weak clusterin up-regulation by complement (0, 12, 24, 48, and
or absent staining; 11 5 weak staining with ,25% of 72 hours) showed its peak expression at 24 hours (Fig. 1
the glomerular tuft showing focally increased staining; A, B). We did not observe any changes in the expression
21 5 25 to 49% of the glomerular tuft showing focally levels of clusterin in mesangial cells without complement
attack (Fig. 1C).increased staining; 31 5 50 to 74% of the glomerular
At 24 hours, neither ATS IgG used for sensitizationtuft demonstrating increased staining; and 41 5 .75%
nor 5% rat serum alone stimulated expression of clus-of the glomerular tuft stained strongly. The average score
terin (Fig. 2 A, B). Furthermore, C6-deficient rat serumwas calculated.
employed as a complement source after ATS sensitiza-
tion did not increase clusterin protein. In contrast, C6-Immunofluorescence study
sufficient rat serum stimulated clusterin expression in
To determine whether clusterin colocalized with C5b-9 mesangial cells when the cells were sensitized with ATS.
in anti-Thy1 nephritis rats, we performed double immu- These results clarified the importance of the terminal
membrane attack complex, C5b-9, in the stimulation ofnostaining with anticlusterin rabbit polyclonal Ig and a
clusterin expression in mesangial cells (Fig. 2C).mouse monoclonal antibody 2A1 against rat C5b-9 [42],
To examine the effect of C5b-9 attack on the expres-which was biotinylated by ECL protein biotinylation
sion of clusterin mRNA in rat mesangial cells, we per-module (Amersham).
formed Northern blot analysis. Clusterin mRNA levelsA rabbit anticlusterin antibody was applied overnight
significantly increased in the rat mesangial cells at 24at 48C, followed by incubation with Texas Red X-conju-
hours after exposure to sublytic complement attack com-
gated goat antirabbit IgG (Molecular Probes Inc., Eu- pared with mesangial cells without stimulation (Fig. 3).
gene, OR, USA). Afterward, a biotinylated mouse
Expression of clusterin mRNA was increased inmonoclonal antibody 2A1 was incubated overnight at
glomeruli of anti-Thy1 nephritis rats48C, followed by Oregon green/Neutralite Avidin (Mo-
To determine the expression of clusterin mRNA inlecular Probes Inc.).
anti-Thy1 nephritis, Northern blot analysis was per-
formed utilizing RNA obtained from isolated glomeruli.Measurement of proteinuria and blood urea nitrogen
Clusterin mRNA was markedly up-regulated in the glo-The urinary protein excretion of the rats was measured
meruli of the OX-7–treated rats on both day 8 and day
by DC protein assay (Bio-Rad). Measurement of blood 29 in comparison with control rats (Fig. 4).
urea nitrogen was performed by the urease-indophenol To localize the sites of clusterin mRNA synthesis, we
method with Urea N B (Wako Pure Chemical Indus- performed in situ hybridization. Signals for clusterin
tries). mRNA were markedly increased in the glomeruli of the
anti-Thy1 nephritis rats on day 8 compared with control
rats (Fig. 5). On day 29, the degree of clusterin mRNAStatistical analysis
expression in the glomeruli of the anti-Thy1 nephritisAll values were presented as means 6 SD. Statistical
rats was still higher than that of control rats (data notcomparisons were analyzed with the program StatView
shown).
(Abacus Concepts, Berkeley, CA, USA) using the analy-
sis of variance followed by the Bonferroni/Dunn method Clusterin deposited in glomeruli of anti-Thy1
nephritis ratsfor multiple group comparisons and paired or unpaired
Student t test as appropriate. A P value of less than 0.05 To evaluate whether up-regulation of clusterin mRNA
could result in protein expression within glomeruli, wewas considered statistically significant.
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performed immunohistochemical analysis with anticlus-
terin Ig. Our studies demonstrated increased clusterin
deposition in the glomeruli in the OX-7–treated rats on
both day 8 and day 29 in comparison with the control
rats (Fig. 6).
Semiquantitation of clusterin staining confirmed a sig-
nificant increase in the expression of clusterin in the
glomeruli of the anti-Thy1 nephritis rats on both days 8
and 29 in comparison with the control rats [anti-Thy1
nephritis rats (N 5 6) and control rats (N 5 6) at day
8, 3.95 6 0.05 and 1.30 6 0.443, respectively, P , 0.05;
anti-Thy1 nephritis rats (N 5 6) and control rats (N 5
6) at day 29, 3.76 6 0.12 and 1.48 6 0.51, respectively,
P , 0.05; Fig. 7].
Clusterin colocalized with C5b-9 in glomeruli of
anti-Thy1 nephritis rats
By immunofluorescence double staining with anti-
clusterin rabbit Ig and a biotinylated mouse monoclonal
antibody 2A1 against rat C5b-9, we examined whether
the glomerular deposition of clusterin in anti-Thy1 ne-
phritis was associated with C5b-9 formation on resident
glomerular cells. Clusterin deposition colocalized with
C5b-9 formation in many glomeruli at day 8, although
it was also observed in the mesangial area without C5b-9
staining (Fig. 8). C5b-9 deposits were not seen in anti-
Thy1 nephritis rats on day 29.
Correlation between clusterin expression and
biochemical parameters
The biochemical data of the experimental animals are
summarized in Table 1. On day 8 after the injection,
urinary protein excretion and blood urea nitrogen in the
anti-Thy1 nephritis rats (272 6 32.0 mg/kg/day and
19.3 6 1.54 mg/dL) were significantly higher than in the
control rats (86.2 6 33.3 mg/kg/day and 13.8 6 1.25
mg/dL, P , 0.01, respectively). In contrast, neither pa-
rameter in anti-Thy1 nephritis rats on day 29 differed
significantly from those in the controls. There was no
relationship between the expression levels of clusterin
and the biochemical parameters in anti-Thy1 nephritis
rats.
Fig. 1. Temporal profile of secretion of clusterin protein by rat mesan-
gial cells stimulated by sublytic complement attack. (A) Western blot DISCUSSION
of concentrated culture medium of rat mesangial cells. Each lane con-
tains 100 mg of protein. Clusterin is present as an a-subunit of 35 kD Previous studies demonstrated that clusterin is consti-
under reducing conditions. The data are representative of four separate tutively expressed in normal tubules and is up-regulatedexperiments. (B) Densitometric analysis of each lane. Data are ex-
after a variety of renal injuries [43–50]. Localization ofpressed as percentage of control (0 hour, h) of four separate experi-
ments. The peak of clusterin in the cultured media is at 24 hours after clusterin has also been found in glomeruli in human and
the stimulation (*P , 0.05). (C) A time control for the time course of experimental membranous nephropathy, correspondingthe expression of clusterin protein. The expression of clusterin in rat
to deposition of complement membrane attack complexmesangial cells without complement attack did not increase over time.
The data are representative of four separate experiments. C5b-9 [20, 51, 52]. Laping et al disclosed that thrombin
can induce clusterin mRNA in both glomerular epithelial
cells and mesangial cells in vitro [53]. While it remains
controversial whether the clusterin observed in the glo-
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Fig. 2. Western blot of clusterin secreted by rat mesangial cells stimu-
lated by sublytic complement attack. (A) Concentrated supernatant
protein (100 mg) was separated by SDS-PAGE under reducing condi-
tions and was processed for immunoblotting with anticlusterin antibody
as described in the Methods section. The data are representative of
four separate experiments. (B) Densitometric analysis of four separate
experiments. Data are represented as percentage of control (h) for
each experiment. Clusterin was markedly increased in the supernatants
of mesangial cells at 24 hours after stimulated by sublytic complement
attack. Either ATS IgG, 5% rat serum, or DMEM alone did not induce
up-regulation of clusterin (*P , 0.05). (C) Western blot of the culture
medium of rat mesangial cells incubated with 5% C6-sufficient rat serum
or 5% C6-deficient rat serum after ATS sensitization. No increased
expression of clusterin was seen in rat mesangial cells at 24 hours after
the incubation in 5% C6-deficient rat serum with ATS sensitization.
The data are representative of four separate experiments.
meruli is synthesized by resident glomerular cells or is glomerular C5b-9 formation and increased proteinuria
when complement-mediated podocyte injury was in-derived from the circulation [50, 54, 55], recent studies
have suggested that clusterin is expressed by intrinsic duced [10]. C5b-9 deposition in human and experimental
membranous nephropathy was associated with clusteringlomerular cells under certain pathological conditions
[52, 53]. [20, 50, 51]. It was speculated that these proteins were
not deposited by entrapment of soluble C5b-9/clusterinIn the present study, we have demonstrated that clus-
terin protein and mRNA can be induced in cultured complexes preformed in the circulation, since the com-
plex was too large to migrate through the glomerularmesangial cells stimulated by sublytic complement at-
tack, which is also known to induce production of several capillary wall [51], and the clusterin associated with
C5b-9 in membranous nephropathy may have been syn-inflammatory mediators in mesangial cells [56]. More-
over, glomerular clusterin mRNA was up-regulated in thesized by resident glomerular cells.
Our double immunostaining demonstrated colocaliza-anti-Thy1 nephritis, a C5b-9–dependent mesangioproli-
ferative nephritis model of rats [56]. This was associated tion of clusterin and C5b-9 deposition in the mesangial
area on day 8 of the anti-Thy1 nephritis. Although wewith increased clusterin deposition in the glomeruli.
It has been reported that clusterin has an important cannot exclude the possibility that the glomerular local-
ization of clusterin observed in immunohisochemicalrole in modulating complement-induced injury. For ex-
ample, in vitro, clusterin was demonstrated to be an staining may have resulted from a deposition of plasma-
or platelet-derived clusterin into the membrane attackinhibitor of C5b-6 reactive hemolysis [31], and kidneys
perfused with clusterin-depleted plasma developed more complex [54, 55], our in vitro and in vivo studies suggest
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Fig. 3. Induction of clusterin mRNA in cultured rat mesangial cells
stimulated by sublytic complement attack. (A) Northern blot for total
RNA (10 mg per lane) from rat mesangial cells with or without stimula-
tion by C5b-9 attack was probed for clusterin and GAPDH. The data
are representative of four separate experiments. (B) Densitometric
quantitation of the blots. The results were expressed as means 6 SD
Fig. 4. Induction of clusterin mRNA in anti-Thy1 nephritis. (A) North-(N 5 4) of the relative ratio of clusterin/GAPDH mRNA. The expres-
ern blot of glomerular total RNA (10 mg per lane) extracted fromsion of clusterin mRNA was significantly increased in rat mesangial
control rats 8 days (N 5 6) and 29 days (N 5 6) after vehicle injection,cells at 24 hours after the incubation of 5% normal rat serum with ATS
and experimental rats 8 days (N 5 6) and 29 days (N 5 6) after OX-7sensitization compared with that of DMEM alone (*P , 0.05).
injection. Each lane represents a separate rat. The Northern blot was
hybridized with a clusterin cDNA probe and a GAPDH cDNA probe.
(B) Densitometric quantitation of the blots. The results are expressed
as means 6 SD (N 5 6) of the clusterin/GAPDH mRNA ratio. A
marked induction of clusterin mRNA is seen in the anti-Thy1 nephritis
rats compared with control rats (*P , 0.05).
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Fig. 5. In situ hybridization for clusterin mRNA in the glomeruli of
the OX-7–treated rats (A and B) and control rats (C and D) on day 8
using antisense (A and C) and sense (B and D) probes. Note the Fig. 7. Semiquantitation of clusterin staining confirmed increased de-
increased expression of clusterin mRNA in the glomeruli of the OX- position of clusterin. Clusterin staining in the glomeruli was significantly
7–treated rats (A) compared with control rats (C; 3400). No signal is increased in the OX-7–treated rats both at day 8 and at day 29 compared
observed in clusterin sense-probed kidney sections (B and D; 3400). with control rats. *P , 0.05.
Fig. 6. Immunohistochemical analysis shows increased deposition of
Fig. 8. Clusterin colocalized with C5b-9 in glomeruli of anti-Thy1 ne-clusterin in anti-Thy1 nephritis rats. Clusterin staining of the OX-7–
phritis rats on day 8. Double immunofluorescent staining for clusterintreated rats (A and C) or control rats (B and D) at day 8 (A and B)
in red (Texas red X; A) and C5b-9 in green (Oregon green; B) demon-and at day 29 (C and D). Significantly increased staining of clusterin
strates the overlapping distribution of these proteins during comple-was seen in the glomeruli of the OX-7–treated rats (3400).
ment-mediated injury. The overlapping area appeared orange on the
merged images (C; 3400).
that expression of clusterin could be induced in glomeru- mRNA in glomerular cells, suggest that resident glomer-
ular mesangial cells attacked by complement inducedlar mesangial cells during the course of experimental
mesangioproliferative glomerulonephritis. Our in situ expression of clusterin as a defensive mechanism. Al-
though some mesangial regions showed clusterin withouthybridization studies, showing up-regulation of clusterin
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Table 1. Urinary protein excretion and blood urea nitrogen (BUN) deposition. This up-regulation of clusterin suggests that
in control rats and in the OX-7–treated rats
clusterin may play a critical role in protecting mesangial
Control OX-7–treated cells from C5b-9–mediated injury induced by anti-Thy1.1
rats rats t-test antibody.
Day 8
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